Project Grant R34AA032398
Award Date 8/5/26
Completion Date 7/31/29
Dollars Obligated $710K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism awarded Brown University $628,846 on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate virtual reality interventions that immerse patients with alcohol use disorder in realistic high-risk situations to help them identify triggers, experiment with coping strategies, and practice deploying those strategies in simulated environments. The project addresses a treatment gap: only about one-third of...
- The National Institute on Alcohol Abuse and Alcoholism awarded Brown University $566,650 on June 16, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and pilot-test a telehealth couples intervention for reducing unhealthy alcohol use among sexual and gender minority persons. The project, titled "Reducing Alcohol Consumption for Health Together," will adapt an existing three-session couples-based intervention called REACH2GETHER, originally developed for cisgender male...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Rhode Island $1,403,716 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine transactional relationships between sensor-derived alcohol use data and acute suicide risk during community re-entry following residential alcohol use disorder treatment. The research uses ecological momentary assessment and transdermal alcohol sensor technology (BACtrack Skyn) to assess time-varying,...
- The National Institute on Alcohol Abuse and Alcoholism awarded Brown University $1,429,670 on September 18, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a 12-week, double-blind, randomized controlled trial testing probenecid as a treatment for alcohol use disorder. The study enrolls 120 individuals with alcohol use disorder and compares probenecid (2 grams daily) to placebo across three primary aims: reducing acute alcohol craving in an alcohol cue reactivity procedure,...
- The National Institute on Alcohol Abuse and Alcoholism awarded Brown University $100,228 on November 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a project grant examining alcohol and adverse childhood experiences as converging risk factors for immune dysregulation. The study leverages existing biological and behavioral data from the Center for Addiction and Disease Risk Exacerbation (CADRE) to investigate how alcohol use and exposure to adverse childhood experiences...
- The National Institute on Alcohol Abuse and Alcoholism awarded Research Triangle Institute $1,411,804 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a hybrid implementation effectiveness cluster-randomized trial of Better Informed Parents Keeping Adolescents Safe from Alcohol (BIPAS), a mobile-delivered digital intervention designed to help parents prevent early-onset alcohol use in children. The study will expand BIPAS reach by translating the intervention...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $182,183 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop artificial intelligence agents that generate personalized, multimedia cognitive behavioral therapy content for alcohol use disorder treatment, targeting English speakers and Spanish speakers. The project will create AI-generated CBT content delivered via smartphone to address high-risk drinking periods, such as weekends. The...
- The National Institute on Alcohol Abuse and Alcoholism awarded New York University School of Medicine $2.920164 million on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate a precision prevention approach for identifying and addressing behavioral health treatment gaps that drive suicide risk. The project will identify subgroups at highest risk of suicidal thoughts and behaviors, characterize which combinations of mental and substance use disorders place...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Massachusetts General Hospital a $735,930 Project Grant (R34) on September 23, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop, validate, and conduct an open trial of a large language model (LLM)-based conversational agent for delivering brief alcohol interventions to emerging adults ages 18-29. The project, which runs through August 31, 2028, addresses the critical public health need to expand screening...
- The National Institute on Drug Abuse awarded Brown University $480,276 under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 1, 2026, to co-develop a brief intervention with young adults aged 18–25 who have opioid use disorder and prematurely terminated treatment, aimed at reducing overdose risk and reengaging participants in evidence-based medication for opioid use disorder (MOUD). The K99/R00 award funds two phases of research. During the K99 phase, the project will...